Michael R. Jaff - 16 Apr 2026 Form 4 Insider Report for HeartBeam, Inc. (BEAT)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
16 Apr 2026, 20:47:53 UTC
Prior SEC filing
23 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Michael R. Jaff

Key filing fact

Michael R. Jaff filed Form 4 for HeartBeam, Inc. (BEAT) on 16 Apr 2026.

Key facts

  • This page summarizes Michael R. Jaff's Form 4 filing for HeartBeam, Inc. (BEAT).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 16 Apr 2026, 20:47.

Change

  • Previous filing in this sequence was filed on 23 Mar 2026.
  • Current net transaction value: +$25,000.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001988352 Primary reporting owner

JAFF MICHAEL R

Relationship
Director
Address
2118 WALSH AVENUE, SUITE 210, SANTA CLARA
Signature
/s/ Michael R. Jaff
Signature date
16 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BEAT transaction

Common Stock

Purchase

Transaction value
$25,000
Shares
+31,250
Change %
Price
$0.8000
Shares after
31,250
Date
16 Apr 2026
Ownership
See Footnote
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These shares were purchased in connection with the Registrant's underwritten public offering of 12,500,000 shares of common stock. Titan Partners, a division of American Capital Partners, acted as the sole bookrunner for the offering, which priced on April 14, 2026, and closed on April 16, 2026.

Footnote F2

The shares are indirectly held by the Reporting Person under the entity Open Book Healthcare.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .